Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02604836 · ClinicalTrials.gov registry record · Phase 4

A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia

A Phase 4 study of Postmenopausal Osteoporosis, sponsored by Hoffmann-La Roche.

Completed
Registry status
Phase 4
Development phase
1,711
Enrollment target
20
Study locations

NCT02604836 is a Phase 4 study of Postmenopausal Osteoporosis that has completed, run by Hoffmann-La Roche. The registered enrollment target is 1,711 participants, above the 444-participant average among 12 other Postmenopausal Osteoporosis trials with a reported enrollment target (285% higher). The trial reports 20 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02604836, a Phase 4 study of Postmenopausal Osteoporosis, has completed, sponsored by Hoffmann-La Roche.

COMPLETED
Registry status
Phase 4
Development phase
1,711 participants
Enrollment target
20
Study locations

Study Summary

This study will investigate participant satisfaction (including compliance, preference, tolerability) with once-monthly Bonviva in women with post-menopausal osteoporosis or osteopenia transitioned from once-weekly alendronate or risedronate. The anticipated time on study treatment is 6 months, and the target sample size is 1776 individuals.

Conditions Studied

Postmenopausal Osteoporosis

Interventions

  • DRUG Ibandronate

Study Locations (20)

Arizona

  • - Chandler
  • - Gilbert
  • - Paradise Valley
  • - Phoenix
  • - Phoenix
  • - Tempe
  • - Tucson

Arkansas

  • - Carlisle
  • - Jonesboro
  • - Little Rock
  • - Pine Bluff
  • - Rogers
  • - Searcy
  • - Sherwood

Alabama

  • - Birmingham
  • - Columbiana
  • - Huntsville
  • - Mobile
  • - Montgomery

California

  • - Anaheim

Trial Details

FieldValue
Enrollment Target 1,711 participants
Start Date 2004-06
Est. Completion 2006-04
Phase Phase 4

Sponsor

Hoffmann-La Roche

909 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02604836

The ClinicalTrials.gov registry entry for NCT02604836 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,711 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 444-participant average among 12 other Postmenopausal Osteoporosis trials with a reported enrollment target (285% higher). The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Postmenopausal Osteoporosis appearing as the primary indexed condition, and to 1 intervention - of which Ibandronate is the first listed.

NCT02604836 reports 20 study locations spanning 4 distinct geographic areas - top geographies include Arizona, Arkansas, Alabama.

Frequently Asked Questions

What is clinical trial NCT02604836 about?

NCT02604836 is a clinical study titled "A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia". This study will investigate participant satisfaction (including compliance, preference, tolerability) with once-monthly Bonviva in women with post-menopausal osteoporosis or osteopenia transitioned from once-weekly alendronate or risedronate. The anticipated time on study treatment is 6 months, and ...

What is the current status of trial NCT02604836?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,711 participants. The study started on 2004-06. Estimated completion is 2006-04.

What conditions does trial NCT02604836 study?

This clinical trial studies the following conditions: Postmenopausal Osteoporosis.

What interventions are being tested in trial NCT02604836?

The interventions under investigation include: Ibandronate (DRUG).

Who is sponsoring clinical trial NCT02604836?

This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02604836 being conducted?

This trial has 20 study locations across Alabama, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Postmenopausal Osteoporosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Postmenopausal Osteoporosis

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.